120 related articles for article (PubMed ID: 11791008)
1. Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease.
Kal JE; Spaan JA; van Wezel HB
J Cardiovasc Pharmacol; 2002 Feb; 39(2):225-33. PubMed ID: 11791008
[TBL] [Abstract][Full Text] [Related]
2. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilation in patients with coronary artery disease.
Kal JE; Vergroesen I; van Wezel HB
Anesth Analg; 1999 Feb; 88(2):271-8. PubMed ID: 9972740
[TBL] [Abstract][Full Text] [Related]
3. Metabolic coronary-flow regulation and exogenous nitric oxide in human coronary artery disease: assessment by intravenous administration of nitroglycerin.
Kal JE; Van Wezel HB; Porsius M; Vergroesen I; Spaan JA
J Cardiovasc Pharmacol; 2000 Jan; 35(1):7-15. PubMed ID: 10630728
[TBL] [Abstract][Full Text] [Related]
4. Coronary collateral blood flow in acute myocardial ischemia is not increased by dihydropyridine-induced coronary vasodilatation.
Sjöquist PO; Duker G; Almgren O
J Cardiovasc Pharmacol; 1985; 7(4):630-6. PubMed ID: 2410700
[TBL] [Abstract][Full Text] [Related]
5. Myocardial oxygen supply:demand ratio as reference for coronary vasodilatory drug effects in humans.
Vergroesen I; Kal JE; Spaan JA; Van Wezel HB
Heart; 1997 Aug; 78(2):117-26. PubMed ID: 9326983
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.
Michaels AD; Klein A; Madden JA; Chatterjee K
Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984
[TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of the rate pressure product as index of myocardial oxygen consumption for the study of metabolic coronary flow regulation.
Kal JE; Van Wezel HB; Vergroesen I
Int J Cardiol; 1999 Oct; 71(2):141-8. PubMed ID: 10574399
[TBL] [Abstract][Full Text] [Related]
8. Role of K+ATP channels in local metabolic coronary vasodilation.
Richmond KN; Tune JD; Gorman MW; Feigl EO
Am J Physiol; 1999 Dec; 277(6):H2115-23. PubMed ID: 10600828
[TBL] [Abstract][Full Text] [Related]
9. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
11. Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans.
Farouque HM; Worthley SG; Meredith IT
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):905-10. PubMed ID: 15016638
[TBL] [Abstract][Full Text] [Related]
12. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo.
Yada T; Shimokawa H; Hiramatsu O; Shinozaki Y; Mori H; Goto M; Ogasawara Y; Kajiya F
J Am Coll Cardiol; 2007 Sep; 50(13):1272-8. PubMed ID: 17888845
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin.
Winniford MD; Jansen DE; Reynolds GA; Apprill P; Black WH; Hillis LD
Am J Cardiol; 1987 Feb; 59(4):203-7. PubMed ID: 3101478
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
15. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
Zygelman M; Mérillon JP; Guiomard A; Eustigneff T; Zannier D; Gourgon R
Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-derived nitric oxide does not modulate metabolic coronary vasodilation induced by tachycardia in dogs.
Katsuda Y; Egashira K; Akatsuka Y; Narishige T; Shimokawa H; Takeshita A
J Cardiovasc Pharmacol; 1995 Sep; 26(3):437-44. PubMed ID: 8583786
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease.
Valsson F; Lundin S; Kirnö K; Hedner T; Houltz E; Saito Y; Ricksten SE
Anesth Analg; 1999 Feb; 88(2):279-85. PubMed ID: 9972741
[TBL] [Abstract][Full Text] [Related]
19. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcium antagonists, felodipine and nicardipine, on cerebral circulation in dogs.
Tanaka M; Yoshida Y; Mitomi A; Nakazawa M; Imai S
Jpn J Pharmacol; 1990 Feb; 52(2):273-9. PubMed ID: 2313936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
